Showing results (1771-1780 of 1,843) with videos related to

Sort By:
Pageof 185
ACS Medicinal Chemistry Letters|April 22, 2022
Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an In Vivo Efficacious TLR7/8 AntagonistClaudia Betschart, Michael Faller, Florence Zink, et al.
Gastroenterology|January 28, 2014
Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomesAng Li, Jennifer P Morton, YaFeng Ma, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2020
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France projectH Blons, J-B Oudart, J-P Merlio, et al.
Cell|October 22, 2024
P-stalk ribosomes act as master regulators of cytokine-mediated processesAnna Dopler, Ferhat Alkan, Yuval Malka, et al.
Progress in Community Health Partnerships : Research, Education, and Action|February 10, 2025
Using ENGAGED for CHANGE to Develop a Multicultural Intervention to Reduce Disparities among Sexual and Gender Minorities in AppalachiaScott D Rhodes, Amanda E Tanner, Jorge Alonzo, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune DiseasesPhil Alper, Claudia Betschart, Cédric André, et al.
PLOS Global Public Health|September 27, 2023
Persuasive COVID-19 vaccination campaigns on Facebook and nationwide vaccination coverage in Ukraine, India, and PakistanMaike Winters, Sarah Christie, Chelsey Lepage, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|October 14, 2025
A Bilingual HIV Status-Neutral Intervention to Promote Heath Equity Among GBQMSM and Transgender and Nonbinary Persons in Appalachia: Outcomes From the Appalachian Access Project Intervention TrialAmanda E Tanner, Lilli Mann-Jackson, Jorge Alonzo, et al.
Schizophrenia Bulletin|June 1, 2023
The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled TrialLidia Engel, Mario Alvarez-Jimenez, Daniela Cagliarini, et al.
Nature Medicine|October 6, 2020
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trialAlain P Algazi, Megan Othus, Adil I Daud, et al.
Pageof 185